AntagomiR-based therapy for pulmonary arterial hypertension: MIRNA-7 increases pulmonary arterial hypertension via down regulation of its target gene, 11/February/2015, 23.07

AntagomiR-based therapy for pulmonary arterial hypertension: MIRNA-7 increases pulmonary arterial hypertension via down regulation of its target gene, 11/February/2015, 23.07

AntagomiR-based therapy for pulmonary arterial hypertension: MIRNA-7 increases pulmonary arterial hypertension via down regulation of its target gene, 11/February/2015, 23.07 150 150

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Significance: This study suggests, for the first time, that MiRNA-7, by suppressing the expression of its target gene, it may increase pulmonary arterial hypertension. Thus, pharmacological formulations encompassing “MiRNA-7 inhibitors“ may be used to treat pulmonary arterial hypertension (PAH).

Amount: $ 300*

Undisclosed information: How MiRNA-7  increases pulmonary arterial hypertension

To cite: Boominathan, AntagomiR-based therapy for pulmonary arterial hypertension: MIRNA-7 increases  pulmonary arterial hypertension via down regulation of its target gene, 11/February/2015,  23.07,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Share
Start Typing